107 related articles for article (PubMed ID: 28138148)
1. Many faces of SMCHD1.
Wilkie AO
Nat Genet; 2017 Jan; 49(2):176-178. PubMed ID: 28138148
[TBL] [Abstract][Full Text] [Related]
2. Role of the Chromosome Architectural Factor SMCHD1 in X-Chromosome Inactivation, Gene Regulation, and Disease in Humans.
Wang CY; Brand H; Shaw ND; Talkowski ME; Lee JT
Genetics; 2019 Oct; 213(2):685-703. PubMed ID: 31420322
[TBL] [Abstract][Full Text] [Related]
3. FSHD2- and BAMS-associated mutations confer opposing effects on SMCHD1 function.
Gurzau AD; Chen K; Xue S; Dai W; Lucet IS; Ly TTN; Reversade B; Blewitt ME; Murphy JM
J Biol Chem; 2018 Jun; 293(25):9841-9853. PubMed ID: 29748383
[TBL] [Abstract][Full Text] [Related]
4. SMCHD1 mutation spectrum for facioscapulohumeral muscular dystrophy type 2 (FSHD2) and Bosma arhinia microphthalmia syndrome (BAMS) reveals disease-specific localisation of variants in the ATPase domain.
Lemmers RJLF; van der Stoep N; Vliet PJV; Moore SA; San Leon Granado D; Johnson K; Topf A; Straub V; Evangelista T; Mozaffar T; Kimonis V; Shaw ND; Selvatici R; Ferlini A; Voermans N; van Engelen B; Sacconi S; Tawil R; Lamers M; van der Maarel SM
J Med Genet; 2019 Oct; 56(10):693-700. PubMed ID: 31243061
[TBL] [Abstract][Full Text] [Related]
5. The Epigenetic Regulator SMCHD1 in Development and Disease.
Jansz N; Chen K; Murphy JM; Blewitt ME
Trends Genet; 2017 Apr; 33(4):233-243. PubMed ID: 28222895
[TBL] [Abstract][Full Text] [Related]
6. SMCHD1 mutations associated with a rare muscular dystrophy can also cause isolated arhinia and Bosma arhinia microphthalmia syndrome.
Shaw ND; Brand H; Kupchinsky ZA; Bengani H; Plummer L; Jones TI; Erdin S; Williamson KA; Rainger J; Stortchevoi A; Samocha K; Currall BB; Dunican DS; Collins RL; Willer JR; Lek A; Lek M; Nassan M; Pereira S; Kammin T; Lucente D; Silva A; Seabra CM; Chiang C; An Y; Ansari M; Rainger JK; Joss S; Smith JC; Lippincott MF; Singh SS; Patel N; Jing JW; Law JR; Ferraro N; Verloes A; Rauch A; Steindl K; Zweier M; Scheer I; Sato D; Okamoto N; Jacobsen C; Tryggestad J; Chernausek S; Schimmenti LA; Brasseur B; Cesaretti C; García-Ortiz JE; Buitrago TP; Silva OP; Hoffman JD; Mühlbauer W; Ruprecht KW; Loeys BL; Shino M; Kaindl AM; Cho CH; Morton CC; Meehan RR; van Heyningen V; Liao EC; Balasubramanian R; Hall JE; Seminara SB; Macarthur D; Moore SA; Yoshiura KI; Gusella JF; Marsh JA; Graham JM; Lin AE; Katsanis N; Jones PL; Crowley WF; Davis EE; FitzPatrick DR; Talkowski ME
Nat Genet; 2017 Feb; 49(2):238-248. PubMed ID: 28067909
[TBL] [Abstract][Full Text] [Related]
7. De novo mutations in SMCHD1 cause Bosma arhinia microphthalmia syndrome and abrogate nasal development.
Gordon CT; Xue S; Yigit G; Filali H; Chen K; Rosin N; Yoshiura KI; Oufadem M; Beck TJ; McGowan R; Magee AC; Altmüller J; Dion C; Thiele H; Gurzau AD; Nürnberg P; Meschede D; Mühlbauer W; Okamoto N; Varghese V; Irving R; Sigaudy S; Williams D; Ahmed SF; Bonnard C; Kong MK; Ratbi I; Fejjal N; Fikri M; Elalaoui SC; Reigstad H; Bole-Feysot C; Nitschké P; Ragge N; Lévy N; Tunçbilek G; Teo AS; Cunningham ML; Sefiani A; Kayserili H; Murphy JM; Chatdokmaiprai C; Hillmer AM; Wattanasirichaigoon D; Lyonnet S; Magdinier F; Javed A; Blewitt ME; Amiel J; Wollnik B; Reversade B
Nat Genet; 2017 Feb; 49(2):249-255. PubMed ID: 28067911
[TBL] [Abstract][Full Text] [Related]
8. FSHD type 2 and Bosma arhinia microphthalmia syndrome: Two faces of the same mutation.
Mul K; Lemmers RJLF; Kriek M; van der Vliet PJ; van den Boogaard ML; Badrising UA; Graham JM; Lin AE; Brand H; Moore SA; Johnson K; Evangelista T; Töpf A; Straub V; Kapetanovic García S; Sacconi S; Tawil R; Tapscott SJ; Voermans NC; van Engelen BGM; Horlings CGC; Shaw ND; van der Maarel SM
Neurology; 2018 Aug; 91(6):e562-e570. PubMed ID: 29980640
[TBL] [Abstract][Full Text] [Related]
9. SMCHD1 is involved in de novo methylation of the DUX4-encoding D4Z4 macrosatellite.
Dion C; Roche S; Laberthonnière C; Broucqsault N; Mariot V; Xue S; Gurzau AD; Nowak A; Gordon CT; Gaillard MC; El-Yazidi C; Thomas M; Schlupp-Robaglia A; Missirian C; Malan V; Ratbi L; Sefiani A; Wollnik B; Binetruy B; Salort Campana E; Attarian S; Bernard R; Nguyen K; Amiel J; Dumonceaux J; Murphy JM; Déjardin J; Blewitt ME; Reversade B; Robin JD; Magdinier F
Nucleic Acids Res; 2019 Apr; 47(6):2822-2839. PubMed ID: 30698748
[TBL] [Abstract][Full Text] [Related]
10. Crystal structure of the hinge domain of Smchd1 reveals its dimerization mode and nucleic acid-binding residues.
Chen K; Birkinshaw RW; Gurzau AD; Wanigasuriya I; Wang R; Iminitoff M; Sandow JJ; Young SN; Hennessy PJ; Willson TA; Heckmann DA; Webb AI; Blewitt ME; Czabotar PE; Murphy JM
Sci Signal; 2020 Jun; 13(636):. PubMed ID: 32546545
[TBL] [Abstract][Full Text] [Related]
11. Identification of a pathogenic SMCHD1 variant in a Chinese patient with bosma arhinia microphthalmia syndrome: a case report.
Yang JL; Gu H; Yuan ZZ; Xie XH; Yang YF; Tan ZP
BMC Med Genomics; 2024 May; 17(1):136. PubMed ID: 38773541
[TBL] [Abstract][Full Text] [Related]
12. The epigenetic regulator Smchd1 contains a functional GHKL-type ATPase domain.
Chen K; Dobson RC; Lucet IS; Young SN; Pearce FG; Blewitt ME; Murphy JM
Biochem J; 2016 Jun; 473(12):1733-44. PubMed ID: 27059856
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide binding and mechanistic analyses of Smchd1-mediated epigenetic regulation.
Chen K; Hu J; Moore DL; Liu R; Kessans SA; Breslin K; Lucet IS; Keniry A; Leong HS; Parish CL; Hilton DJ; Lemmers RJ; van der Maarel SM; Czabotar PE; Dobson RC; Ritchie ME; Kay GF; Murphy JM; Blewitt ME
Proc Natl Acad Sci U S A; 2015 Jul; 112(27):E3535-44. PubMed ID: 26091879
[TBL] [Abstract][Full Text] [Related]
14. SMCHD1's ubiquitin-like domain is required for N-terminal dimerization and chromatin localization.
Gurzau AD; Horne CR; Mok YF; Iminitoff M; Willson TA; Young SN; Blewitt ME; Murphy JM
Biochem J; 2021 Jul; 478(13):2555-2569. PubMed ID: 34109974
[TBL] [Abstract][Full Text] [Related]
15. Relating SMCHD1 structure to its function in epigenetic silencing.
Gurzau AD; Blewitt ME; Czabotar PE; Murphy JM; Birkinshaw RW
Biochem Soc Trans; 2020 Aug; 48(4):1751-1763. PubMed ID: 32779700
[TBL] [Abstract][Full Text] [Related]
16. The hinge domain of the epigenetic repressor Smchd1 adopts an unconventional homodimeric configuration.
Chen K; Czabotar PE; Blewitt ME; Murphy JM
Biochem J; 2016 Mar; 473(6):733-42. PubMed ID: 26733688
[TBL] [Abstract][Full Text] [Related]
17. [A Newborn Suffering from Arhinia: Neonatologic Challenges During Primary Care of the Newborn With Bosma Arhinia Microphthalmia Syndrome (BAMS)].
Stromiedel H; Van Quekelberghe C; Yigit G; Al Naimi A; Bahlmann F; Sader R; Guchlerner M; Lüchtenberg M; Latta K; Cho CH; Wollnik B; Kunzmann S
Laryngorhinootologie; 2021 Apr; 100(4):294-296. PubMed ID: 33784779
[TBL] [Abstract][Full Text] [Related]
18. Clinical, muscle pathological, and genetic features of Japanese facioscapulohumeral muscular dystrophy 2 (FSHD2) patients with SMCHD1 mutations.
Hamanaka K; Goto K; Arai M; Nagao K; Obuse C; Noguchi S; Hayashi YK; Mitsuhashi S; Nishino I
Neuromuscul Disord; 2016; 26(4-5):300-8. PubMed ID: 27061275
[TBL] [Abstract][Full Text] [Related]
19. A New Role for SMCHD1 in Life's Master Switch and Beyond.
Schall PZ; Ruebel ML; Latham KE
Trends Genet; 2019 Dec; 35(12):948-955. PubMed ID: 31668908
[TBL] [Abstract][Full Text] [Related]
20. Identification of SMCHD1 domains for nuclear localization, homo-dimerization, and protein cleavage.
Hiramuki Y; Tapscott SJ
Skelet Muscle; 2018 Aug; 8(1):24. PubMed ID: 30071896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
